News

Published on 10 Feb 2024 on GuruFocus.com via Yahoo Finance

PRIMECAP Management's Strategic Exits and New Positions Highlight Q4 Moves


Article preview image

Seagen Inc. Sale Marks Notable Portfolio Change for PRIMECAP Management (Trades, Portfolio)

PRIMECAP Management (Trades, Portfolio), an esteemed investment firm known for its value-driven approach and long-term investment horizon, has revealed its 13F filings for the fourth quarter of 2023. Founded in 1983 and based in Pasadena, CA, PRIMECAP specializes in managing US equity portfolios for institutions and mutual funds. The firm's investment philosophy is anchored in four key principles: individual decision-making, rigorous fundamental research, a long-term perspective, and a keen focus on value. PRIMECAP's multi-counselor model allows each portfolio manager to independently manage a segment of the fund, fostering a diverse range of investment strategies under one roof. The firm is adept at identifying undervalued stocks, particularly in sectors that are currently out of favor, and patiently waits for the market to align with its valuation assessments.

PRIMECAP Management's Strategic Exits and New Positions Highlight Q4 MovesPRIMECAP Management's Strategic Exits and New Positions Highlight Q4 Moves

NASDAQ.SGEN price evolution
NYSE.NVS price evolution
NYSE.IT price evolution
SIX.NOVN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Exploring Swiss Dividend Stocks In May 2024

Amidst a backdrop of fluctuating market conditions, the Swiss market demonstrated resilience, clo...

Simply Wall St. via Yahoo Finance 31 May 2024

Incyte (INCY) Up 7.5% Since Last Earnings Report: Can It Continue?

A month has gone by since the last earnings report for Incyte (INCY). Shares have added about 7.5...

Zacks via Yahoo Finance 30 May 2024

Exploring Three Japanese Growth Companies With High Insider Ownership On The Tokyo Stock Exchange

Amid a backdrop of fluctuating global markets, with Japan's Nikkei 225 experiencing slight declin...

Simply Wall St. via Yahoo Finance 30 May 2024

Goldman Sachs initiates cover on six European pharma stocks

Goldman Sachs initiates cover on six European pharma stocks

Investing.com 30 May 2024

Novartis stock rated 'Buy' by Goldman Sachs, highlighting robust innovation By Investing.com

On Thursday, Goldman Sachs (NYSE:GS) initiated coverage on Novartis AG (SIX:NOVN) stock, listed a...

Investing.com 30 May 2024

Three Leading Swiss Dividend Stocks With Yields Up To 6.1%

Swiss stocks experienced a downturn on Tuesday, influenced by global economic concerns including ...

Simply Wall St. via Yahoo Finance 30 May 2024

Goldman Sachs Says Buy European Pharma Stocks Touting Innovation

(Bloomberg) -- European drugmakers that are focused on building portfolios of new medicines have ...

Bloomberg via Yahoo Finance 30 May 2024

Is Vanguard International Dividend Appreciation ETF (VIGI) a Strong ETF Right Now?

Designed to provide broad exposure to the World ETFs category of the market, the Vanguard Interna...

Zacks via Yahoo Finance 27 May 2024

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information...

U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected...

Benzinga via AOL 24 May 2024

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript

Novartis AG (NYSE:NVS) Q1 2024 Earnings Call Transcript April 23, 2024 Novartis AG isn’t one of t...

Insider Monkey via Yahoo Finance 24 Apr 2024